Corporate
2026.03.03
Dr. Devlin Shares LT3001 Clinical Results in VJNEurology Interview
Dr. Thomas Devlin, one of the principal investigators for Lumosa's LT3001, a novel therapy for acute ischemic stroke, shares the results of LT3001 trials in an interview with Video Journal of Neurology (VJNeurology).
Video Link
Video Link
